SCHEMBL13176522

SCHEMBL13176522

Nc1nc(Cl)c2c(n1)CCS2

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.34
▸ NPC1 O15118 3/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11035315 0.89 KDM4E (0.35) MAPTALDH1A1L3MBTL1KDM4E
SCHEMBL588750 0.79 NPC1 (0.35) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL30712008 0.64 SMN1; SMN2 (0.38) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL2922186 0.63 KDM4E (0.53) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1617798 0.63 KDM4E (0.59) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL9386510 0.62 — —
SCHEMBL11111028 0.62 APOBEC3A (0.32) ALDH1A1
SCHEMBL24954180 0.61 KDM4E (0.57) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL23586251 0.61 PDE10A (0.38) —
SCHEMBL3799303 0.60 PDE4B (0.33) MAPTMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215093-B1 NOVEL PIPERAZINO-DIHYDROTHIENOPYRIMIDINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2011-12-14 — — EP disclosed
EP-1874781-B9 DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES BOEHRINGER INGELHEIM INT (DE) 2010-09-08 — — EP disclosed
EP-1874781-B1 DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES BOEHRINGER INGELHEIM INT (DE) 2009-06-24 — — EP disclosed
Send feedback